Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 765 results for "continuous renal replacement therapy"

1 images for "continuous renal replacement therapy"

IVTEAM, 1 month ago
Jammu and Kashmir Bank Limited

Access donates CRRT machine

The ceremonial handing over of the the Continuous Renal Replacement Therapy (CRRT) machine donated Access International to the medical intensive care unit was held at the Lady Ridgeway Hospital on Tuesday at the new auditorium under the patronage of ...
 Sri Lanka Daily News2 months ago J&K Bank to donate CRRT & Colour Doppler Ultrasound machines to SKIMS  Kashmir Times3 weeks ago J&K Bank donates CRRT, Colour Doppler to SKIMS  Daily Excelsior.com3 weeks ago

Beta-lactam antibiotic dosing during continuous renal replacement therapy: how can we optimize therapy?

Commentary Jan J De Waele and Mieke Carlier Critical Care 2014, 18 :158
 Critical Care2 months ago Antibiotic dosing in critically ill patients with septic shock and on continuous renal replacement therapy: can we resolve this problem with pharmacokinetic studies and dosing guidelines?  Critical Care2 months ago Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy  Critical Care2 months ago

Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012

Migalastat Successfully Meets Both Co-Primary Endpoints of Comparability to Enzyme Replacement Therapy (ERT) on Both Key Measures of Kidney Function Comparability to ERT Also Demonstrated in Important Fabry Disease Biomarker, Plasma Lyso-Gb3 ...
 CEOWorld Magazine1 week ago AMICUS THERAPEUTICS : Announces Positive Phase 3 Data From Fabry Monotherapy Study 012  4 Traders1 week ago Amicus Therapeutics ( FOLD )  Stock Junction1 month ago Amicus Therapeutics Provides Updates and Final Analysis Plan for Phase 3 Fabry Monotherapy Study 012  Market Pulse Navigator2 months ago
[x]  

Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses

The present invention is directed to a stable fluorocarbon emulsion having a continuous aqueous phase and discontinuous fluorocarbon phase comprising two fluorocarbons and surprisingly demonstrates that perfluorodecyl bromide is as effective in ...
 PharmCast2 months ago

Amicus announces positive data from Phase III Fabry disease study

Amicus Therapeutics, Inc., a biopharmaceutical company, has announced positive 18-month data from its second Phase III study, or Study 012, with an oral small molecule chaperone, migalastat HCl, in Fabry patients with amenable mutations. Study 012 ...
 Individual.com2 days ago Amicus Therapeutics, Inc. Rockets On Positive Phase 3 Study Data For Rare Disease Drug; Stock Up +21.66% At 11:38AM ET On Wednesday  BioSpace1 week ago

Amicus Therapeutics' (FOLD) CEO John Crowley on Phase III Fabry Monotherapy Study Results (Transcript)

Operator Good day, ladies and gentlemen, and welcome to the Amicus Phase 3 Fabry monotherapy results conference call. At this time all participants are in a listen only mode. Later we will conduct a question-and-answer session and instructions ...
 Seeking Alpha1 week ago Amicus' (FOLD) CEO John Crowley on Q2 2014 Results - Earnings Call Transcript  Seeking Alpha3 weeks ago

Therapeutic Plasma Exchange in Sepsis and Septic Shock

Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: Efficacy and ...
 General Medicine eJournal1 month ago
EuroInvestor

FDA Approves Genzyme Corporation's Gaucher Disease Pill Cerdelga

FDA Approves Genzyme's Cerdelga (eliglustat) Capsules First-Line Oral Therapy Approved for the Treatment of Adults with Gaucher Disease Type 1 CAMBRIDGE, Mass., Aug 19, 2014 (BUSINESS WIRE) -- Genzyme, a Sanofi company , announced today that ...
 BioSpace1 week ago 8/19/14 - FDA Approves Genzyme??s Cerdelga?ยข (eliglustat) Capsules  Pharmacy Choice1 week ago FDA Approves Genzyme's Cerdelga (eliglustat) Capsules  FierceBiotech1 week ago FDA Approves Genzyme's Cerdelga(TM) (eliglustat) Capsules  CNBC1 week ago
[x]  
Nasdaq

Rockwell Medical, Inc. Reports Second Quarter 2014 Results

(GLOBE NEWSWIRE) -- . (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary ...
 Pettinga Financial Advisors4 weeks ago Rockwell Medical Schedules 2nd Quarter 2014 Investor Conference Call  Yahoo! Finance1 month ago Rockwell Medical Announces FDA Approves $2.2 Million Application Fee Refund for Triferic(TM) NDA  Individual.com2 months ago Rockwell Medical Receives FDA Approval for Calcitriol  Yahoo! Finance2 months ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less